This document discusses inflammation. It begins with historical highlights of inflammation research from ancient Rome to the 20th century. It then defines inflammation and discusses the causes, signs, and process of acute and chronic inflammation. It details the vascular and cellular events of acute inflammation, including leukocyte extravasation and phagocytosis. It also discusses chemical mediators and resolution of inflammation. Inflammation is characterized as the body's response to injury and involves vascular, cellular, and chemical components aimed at removing injurious agents and healing tissues.
5. The word inflammation is derived from the state of being
inflammed.
To inflamme means to “ set afire” which conjurs up the
color red , a sense of heat and often pain
The word is derived from the latin word enflammare
6. HISTORICAL HIGHLIGHTS
W Cornelius Celsus (ancient Rome) described rubor (redness), calor (heat --
this applies only to the skin), dolor (pain), and tumor (which then simply
meant "swelling") as the "cardinal signs of inflammation
WJohn Hunter (the great early surgeon, * 1793, * first
characterized inflammation as a nonspecific body response.
WRudolf Virchow added functio laesa (loss of function) as the
fifth cardinal sign of inflammation, and his student, Julius
Cohnheim, provided the basic studies of the pathologic
microanatomy of inflammation.
W Elie Metchnikoff (* 1892) was the first to observe and study
phagocytosis. (* This is the same Metchnikoff who popularized
yogurt as a "health and longevity food". He died at age 70.)
7. • Paul Ehrlich developed the idea of humoral immunity early in the
20th century. (This is the same Ehrlich who developed the "magic
bullet" for syphilis, and most of the stains we still use.)
• Thomas Lewis demonstrated that inflammation is brought about by
chemical mediators, most of which act locally. Someone may still ask
you about the "triple response of Lewis" to a superficial scratch: (1) an
immediate red scratch mark; (2) a red flare around the scratch mark;
(3) a red swollen area ("wheal") around the flare. (Try it!) Dr. Lewis
found that he could eliminate the flare, but not the others, by cutting
the autonomic nerve supply (i.e., preventing the "axon reflex"). This
experiment led to the discovery of histamine.
8. DEFINITION AND CAUSES
DEFINITION. Inflammation is defined as the local response of living
mammalian tissues to injury due to any agent. It is body defence reaction in
order to eliminate or limit the spread of injurious agent.
AGENTS CAUSING INFLAMMATION.
Physical agents like heat, cold,radiation,mechanical trauma.
Chemical agents like organic and inorganic poisons.
Infective agents like bacteria,virus,parasites.
Immunological agents like cell mediated and antigen-antibody reactions.
10. ACUTE INFLAMMATION
Acute inflammation is the immediate and early response to injury,is of
relatively short duration,lasting from a few minitues up to a few days,and is
characterized by fluid and plasma protien exudation and by a predominantly
neutrophilic leucocyte accumulation.
It has three major components
a) Alteration in vascular caliber
b)Structural changes in microvasculature
c)Emigration of the leucocytes
These changes account for five classical signs of acute inflammation.
1-Heat(calor)
2-Redness(rubor)
3-Swelling(tumor)
4-Pain(dolor)
5-Loss of function(functio laesa)
11. CAUSES OF ACUTE INFLAMMATION
1. MICROBIAL INFECTION
a. Viruses- by death of individual cells or
by intercellular multiplication
b. Bacteria- endotoxins or exotoxins
2. HYPERSENSITIVITY REACTIONS
Parasitic infections
3. PHYSICAL AGENTS
Trauma, Radiation, Heat, Cold
4. IRRITANTS and CORRESIVE CHEMICALS
Acids and Alkalies
12. VASCULAR CHANGES
CHANGES IN VASCULAR FLOW AND CALIBER
• Transient vasoconstriction(seconds)
• Vasodilation involving arteriole first
• Local increase in blood flow
redness and warmth(erythema)
Increased permeability resulting in exudation of protien rich fluid into the extravascular
tissues
Red blood cells become concentrated increasing the viscosity and slowing the
circulation(process called STASIS)
Leucocytes (neutrophils) accumulate along the vascular endothelial surface(process called
MARGINATION)
13. After adhering to endothelial cells the leucocytes squeeze between them and miagrate
through the vascular wall into interstitial tissue(process called emigration)
14.
15. INCREASED VASCULAR PERMEABILITY
• In earliest phase,vasodilation and increased blood flow increase intra vascular hydrostatic
pressure.
• This results in filtration of fluid from the capillaries called Transudate.
• Soon eclipsed by increased vascular permeability ,and flow of protien rich fluid and cells
called Exudate into the interstitium
• This reduces the intravascular osmotic pressure,while increasing the osmotic pressure of the
interstitial fluid.
• Net result is out flow of water and ions into the extravascular tissues ,accumulation is called
Edema.
How does the normally non penetratable endothelial layer become leaky during acute
inflammation ?
16. FIVE MECHANISM ARE KNOWN
Endothelial cell contraction
- Immediate transient response(15-30 min)
- Capillaries and arterioles are unaffected
Junctional retraction
-
-reversible mechanism
-occurs 4-6 hr after initial stimulus
-persists for 24 hr or more
-structural reorganization of cytoskeleton
-induced by cytokine mediator(TNF&IL-1)
17. Direct endothelial injury
-vascular leakage by causing endothelial cell necrosis and detachment
- seen in severe injuries eg burns or infection
- reaction is called immediate sustained response
- venules,capillaries,arterioles,can all be affected
-direct injury may also induce a delayed prolonged leakage,begins after a delay
of
2-12hr.lasts for several hours or even days and involves venules and capillaries
eg mild to moderate thermal injury.Bacterial toxins,uv or x-irradiation
-Attributed to apoptosis,and actions of cytokines.
18. Leukocyte dependent endothelial injury
-due to leukocyte accumulation during inflammatory response
-leukocyte may be activated,releasing toxic oxygen species and proteolytic enzymes
which cause endothelial injury or detachment
-injury restricted to sites where leukocytes can adhere to the endothelium(venules,and
pulmonary capillaries)
19. Increase transcytosis
-via an vesiculovacuolar pathway
-augments venular permeability,following exposure to certain mediators
(vascular endothelial growth factor VEGF)
20. LEUKOCYTE CELLULAR EVENTS
Extravasation of leukocytes from vascular lumen to extravascular space is divided into
Margination and rolling
Adhesion and transmiagration between endothelial cells
Miagration in interstial tissue toward a chemotactic stimulus
21. MARGINATION AND ROLLING
• In normal blood flow red and white blood cells travel along the central axis
• As vascular permeability increases fluid exits the vascular lumen and blood flow slows
• As a result leukocytes settle out of central column, marginating to vessel periphery
• Subsequently they tumble on the endothelium, transiently sticking along the way, a process
called rolling.
ADHESION AND TRANSMIAGRATION
• Leukocytes firmly adhere to the endothelial surface before crawling between the cells and
basement membrane into extravascular space(diapedesis)
• It occurs predominantly in venules of systemic vasculature and capillaries of lungs
• Neutrophils predominate for the first 6-24 hr followed by monocyte in subsequent 24-48hr
22. Neutrophils are short lived,undergoing apoptosis within 24-48hr after exiting the blood
stream
Monocyte survive longer and persists for long periods as tissue macrophages
CHEMOTAXIS AND ACTIVATION
After extravasation leukocyte emigrate toward the site of injury along a chemical gradient in
a process called chemotaxis
Both endogenous and exogenous substances can act as chemotactic agent for leukocyte
including:
-soluble bacterial products,paricularly peptides with N-formyl methionine termini
-components of complement system,particularly C5a
-products of lipoxygenase pathway of arachidonic acid (AA)metabolism,
leukotrieneB4
(LTB4)
-cytokines
23. Chemotactic agents binds to spesific receptor on the leukocyte cell surface and induce an
intracellular cascade of phospholipid metabolites,eventually culminating in increased
intracellular calcium
The increased cytosolic calcium triggers the assembly of cytoskeletal contractile elements
necessary for movement
Leukocytes move by extending pseudopods that anchor themselves to the extracellular matrix
and then pull the remainder of the cell after.
Besides stimulating locomotion ,chemotactic factors also induce other leukocyte
responses,generically referred to as leukocyte activation.
If agents producing the chemotactic factor can be ingested by the leukocyte (ie
phagocytosed)digestion and destruction of the phagocytosed material may yield breakdown
products that have chemotactic properties
Neutrophils themselves can be stimulated to release chemotactic factors that attract
macrophages
24.
25. PHAGOCYTOSIS AND DEGRANULATION
PHAGOCYTOSIS CONSISTS OF THREE STEPS:
• Recognition and attachement of the particle to the ingesting leukocyte
-It is facilitated by coating microorganism with serum proteins generically called Opsonins ,
which in turn bind to specific receptor on the leukocyte
-Most important opsonins are the immunoglobulins(IgG)molecule (specifically the Fc portion of
the molecule),and the C3b fragment of complement(and its stable C3bi form)
-In many cases the binding of IgG is responsible for triggering the activation of the complement
cascade that results in deposition of C3b fragment on targeted particles.
-Microbial surface can directly induce complement activation by IgG Independent alternative
pathway
• Engulfment with subsequent formation of a phagocytic vacuole
-Binding of opsonized particle triggers engulfment
-Psedopods are extended around the object to be engulfed,eventually forming a phagocytic
vacuole.
26. • KILLING OR DEGRANULATION OF THE INGESTED MATERIAL
-The membrane of the phagocytic vacuole then fuses with the membrane of a
lysosomal granule, resulting in discharge of the granules content into the
phagolysosome and degranulation of leukocytes.
-Bacterial and other microbial killing is accomplished largely by reactive oxygen
species.
-Phagocytosis stimulates an oxidative burst ;characterized by a sudden increase in
oxygen consumption.
-Generation of oxygen metabolites is due to rapid activation of a
leukocyte NADPH oxidase,which oxidizes NADPH(reduced nicotinamide adenine
dinucleotide phosphate)and in the process reduces oxygen to superoxide ion .
27. -Superoxide is then converted mostly by spontaneous dimutation into
hydrogen peroxide
-Quantity of hydrogen peroxide produced are insufficient to effectively
kill most bacteria.
-Lysosomes of neutrophils (azurophilic granules) contain the enzyme
myeloperoxidase(MPO)and in the presence of halide converts
hydrogen peroxide to hypocholorous radical which is a powerful
oxidant and antimicrobial agent that kills bacteria by halogenation or
by protein or lipid peroxidation
- Even in absence of oxidative burst other constituent of leukocyte
granules are capable of killing bacteria and other infectious agent,these
include
1)BPI(bactericidal permeability increasing protein)
2)lysosomes
3)lactoferrin and defensins(group of peptides)
34. CHRONIC INFLAMMATION
Chronic inflammation is characterized by
1)Inflitration with mononuclear (chronic inflammatory cell)including
macrophages,lymphocytes and plasma cells.
2)Tissue destruction induced by inflammatory cells
3)Repair involving new vessel proliferation(angiogenesis) and fibrosis.
Chronic inflammation may follow acute inflammation
Chronic inflammation arise in following settings:
1)Persistent infections eg Treponema pallidum(syphilis),mycobacterium
(tubercle bacilli), certain fungi
2)Prolonged exposure to potentially toxic agents
eg non-degradable exogenous material (inhaled particulate
silica)silicosis in lungs,endogenous agents such as elevated plasma lipid
components(atherosclerosis).
35. 3)Autoimmune diseases
Individual develops an immune response to self antigens and tissues ,eg Rheumatoid
artheritis
CHRONIC INFLAMMATORY CELLS
• Macrophages ,which are diffusely scattered in connective tissue,or clustered in organs such
as the liver(kupffer cells),spleen and lymph nodes,CNS,lungs(alveolar macrophages)
• Monocytes emigrate at the site of injury within the first 24 to 48 hr,when they reach
extravascular tissue they undergo transformation into larger phagocytic cells called
macrophages
• Macrophages secrete a wide variety of biologically active products
-Acid and neutral proteases
-complement component and coagulation factors
-reactive oxygen species and NO
-Eicosanoids
-cytokines.IL1,TNF,growth factors
36. At the site of acute inflammation where the irritant is cleared and process is resolved
macrophages eventually die or wander off, into lymphatics. In case of chronic inflammation
macrophage accumulation persists.
Other type of cells are
-lymphocytes (T&B)
-plasma cells
-eosinophils
Plasma cells are the terminally differentiated end products of B-cell activation,produce
antibodies directed against antigen.
Eosinophils found in inflammatory sites around parasitic infections,as part of immune
reaction,mediated by immunoglobulin E(IgE) associated with allergies.
Eosinophil-specific granules contain major basic protiens(MBP), a highly charged cationic
protein that is toxic to parasites but also cause epithelial cell lysis.
37. GRANULOMATOUS INFLAMMATION
• A Distinctive pattern of chronic inflammation characterized by aggregation of activated
macrophages that have acquired an enlarged,squamous cell like (called epitheliod )
appearance
• Tuberculosis is archetypal granulomatous disease.
38.
39.
40. RESOLUTION
Resolution involves the return of injured tissue to normal structure and
function.
Most important cell in resolution is macrophage,it has the responsibility of:
-Phagocytosing
-Digesting dead tissue,dead inflammatory cell,red blood cell and
fibrin in the exudate.
Resolution can only occur if destruction has not been extensive and
parenchymal cells are capable of resolution .
More highly specialized the tissue ,the less the capacity for regeneration.
Cells involved in healing are :
-Neutrophils,release of lysosomal enzyme may contribute to
digestion of debris.
41. -Macrophages, primary role is debridement, other is to secrete growth factors that
stimulate proliferation of fibroblasts and new blood vessels.
-Fibroblast, synthesize and secrete collagen, proteoglycans, fibronectin in the
healing wound. After these molecules are released from the cell they aggregate to form
collagen fibrils. As fibers are formed ,the tensile strength of the wound increases.
-Platelets, platelets participate in clot formation and provide mitogens(substances
that stimulate cell division) and chemoattractants for fibroblast.
• Alternative to resolution is fibrous repair.
42.
43.
44. SYSTEMIC EFFECTS OF INFLAMMATION
• Fever is the most prominent manifestation. it depends on the humoral signals
from the body. It is coordinated by the hypothalamus and involves a wide
range of endocrine, autonomic and behavioral responses. The components of
the so called acute phase reaction include the cytokines(IL-I,IL-6) and TNF.
• Acute phase reaction include,slow-wave sleep,anorexia,hypotension etc.
• IL-6, stimulates hepatic synthesis of plasma proteins notably fibrinogen,
which cause erythrocyte to agglutinate.
• IL-1 and TNF, act on the thermoregulatory center of the hypothalamus via
local prostaglandin E production to induce fever( hence the efficacy of asprin
and NSAIDs in reducing fever).
• Leukocytosis (increased white blood cell count,15000 or 20000 cells/ micro
liter )
• Parasitic infections induce eosinophilia.
45.
46. GINGIVAL INFLAMMATION
The sequence of events in the development of gingivitis is analyzed in three
different stages
1-Stage one gingivitis:The initial lesion First manifestation of gingival
inflammation are vascular changes,dilation of capillaries and increased blood
flow.Clinically this response to bacterial plaque is not apparent.
2-Stage two gingivitis :the early lesion After 4-7 days clinical signs of
erythema may appear,prominent cells are lymphocytes,bleeding on probing
may also be evident
3-Stage three gingivitis:the established lesion In chronic gingivitis(stage III)
the blood vessels become engorged and congested ,venous return is
impaired,and the blood flow becomes sluggish,results in localized gingival
anoxemia,which superimposes a some what bluish hue on the reddened
gingiva.
47. • STAGE FOURTH GINGIVITIS:THE ADVANCED LESION
Extension of the lesion into alveolar bone characterizes a fourth stage that has been named the
advenced lesion or phase of periodontal breakdown.
CLINICAL FEATURES OF GINGIVITIS
• Gingival bleeding-from gingival sulcus on gentle probing
• Color changes –in chronic gingivitis red or bluish red color(normal is coral pink),in acute
gingivitis change may be marginal,diffuse,or patch like
• Changes in consistency-(normally firm and resilient) both destructive(edematous) and
reparative(fibrotic)changes coexist and consistency is determined by their relative
predominance.
• Change in surface texture-loss of stippling,in chronic inflammation surface is either smooth
and shiny or firm or nodular.
• Gingival recession
• Changes in contour
49. PERIODONTITIS
Periodontitis results from extension of the inflammatory process
initiated in the gingiva to the supporting structures of the tooth
It can be classified as:
-Slowly progressive periodontitis(adult periodontitis)
-Rapidly progressive periodontitis:
1-Adult onset(age >20 yr)
2-Pubertal and adolescent onset(age 11-19 yr)
3-Prepubertal onset(age<11 yr)
-Nectrosing ulcerative periodontitis
-Refractory periodontitis
50. Clinical features are:
-Gingival inflammation
-Loss of stippling
-Blunted or rolled gingival margins
-Flattened or cratered papillae
-Bone loss
-Infrabony pockets
52. Prosthodontic considerations
• Post-extraction,and after preprosthetic surgical procedures tissue need to be given rest
to heal,inflammaed mucosa can be detected clinically,no specific protocol exist,but at
least a min of 15 days rest is given.(time required for a wound to heal by secondary
intention)
• Sequeale caused by wearing removable prosthesis
53. • In the interface between a prosthesis and the oral mucosa,microbial plaque may have
important negative or harmful effects.
• A prosthesis may promote infection of the underlying mucosa,caries and periodontal
disease adjacent to overdenture abutments ,periimlant gingivitis and chemical
degradation or corrosion of prosthetic materials.
54. Direct sequelae caused by wearing dentures
Denture stomatitis-(denture sore mouth or inflammatory papillary hyperplasia or
chronic atrophic candidosis) In randomized population the prevalence of denture
stomatitis is 50% among complete denture wearer.
Classification
Type I –a localized simple inflammation or pinpoint hyperemia
55. Type II- An erythematous or generalized simple type seen as more diffuse erythema
involving a part or the entire denture covered mucosa.
Type III-Granular type (inflammatory papillary hyperplasia), commonly in central part of
the hard palate and alveolar ridges.
57. Strains of genus candida ,in particular Candida albicans, may cause denture stomatitis. Still
this condition Is not a spesific disease entity because other causal factors exist such as
bacterial infection,mechanical irritation,or allergy.
Etiology- TypeI most often is trauma induced, typeIIand typeIII most often are caused by
microbial plaque accumulation(bacteria and yeast) on the fitting denture surface and the
underlying mucosa.
Association of candida with angular chelitis or glossitis indicates a spread of the infection
from the denture covered mucosa to the angles of the mouth or the tounge.
Predisposing factors are presence of denture in the oral cavity,wearing denture day and
night,infection disappear if dentures are not worn.
Other important factors that can modulate host-parasite relationship and increase the
suseptibility to candida–associated denture stomatitis may be ageing ,malnutrition,
immunosuppresion, raditation therapy,diabetes mellitus ,antibacterial antibiotics.
58.
59.
60. Management and preventive measures
Efficient plaque control/correction of denture wearing habits, patients should
be instructed to remove the denture during night,after meals and scrub them
with soap before reinserting them.
Mucosa should be kept clesn and massaged with soft toothbrush
Old and ill fitting dentures should be replaced or corrected,rough areas should
be smoothed or relined with soft tissue conditioner.
Anti-fungal drugs used in patients where clinical diagnosis has been confirmed
by mycological examination, burning sensation, infection has spread to
pharynx or, patient with debilitating diseases.
Local therapy with nystatin, amphotericinB, miconazole, clotrimazole,
preferred to systemic therapy with ketaconazole or fluconazole because of
resistance of candida species.
61. • For the reduction in the risk of relapse following precautions should be taken
-treatment with anti fungal for four weeks
-when lozenges are used denture should be taken out during sucking
- Maintain denture hygiene, wear denture as seldom as possible,keep them dry in
disinfectant solution of 0.2% to 2.0% chlorhexidine during nights.
62. Fixed partial denture
Periodontal factors- The goals of periodontal therapy for the prosthodontic
patient are: -Resolve inflammation
-Convert periodontal pocket depths to clinically normal sulcular
depths
-Establish physiologic gingival architecture
-Provide adequate zone of attached gingiva
-Adequate oral hygiene
Margin placement- the gingiva are healthiest when margins are placed well
above(ie 1-2mm)the gingival crest.
Biologic width- to avoid encroaching on the biologic width ,the tooth
preparation must terminate at least 2mm coronal to alveolar crest.
Severing the natural dentogingival attachment will produce chronic gingival
inflammation, pocket formation, and osseous defects.
66. Periodontal injury caused by occlusal forces is called trauma from occlusion.
Occlusal traumatism does not affect the gingiva ,however in presence of inflammation it
alters the path of inflammation into the periodontal ligament space and lead to
infraosseous pockets.
This does not affect the marginal gingiva , but affects the bone ,this is called the zone of
codestruction: trauma from occlusion in presence of inflammation.
A classic example is poorly constructed RPD that causes gingival irritation with
concomitant twisting force to the abutment tooth.
67. PERIODONTITIS vs PERIIMPLANTITIS THE SAME
DISEASE ? THE SAME TREATMENT ?
The soft and hard tissues surrounding an osseointegrated implant show some
similarities Difference lies in collagen fiber being nonattached and parallel to
implant surface.
A periodontitis like process,periimplantitis can affect dental implants and can
result in loss of implant.
Bacterial plaque is the primary etiological factor in loss of both teeth and
implant.
Clinical findings include marked gingival inflammation,deep pocket, and
progressive bone loss.
Indications for implant removal
-Severe peri implant bone loss(>50% of implant length)
-Bone loss involving implant vents or holes
-Rapid ,severe bone destruction(within one year of loading)
-Non surgical and surgical therapy ineffective
68. Initial phase of treatment of peri-implantitis
-Occlusal therapy- analysis of the fit of prosthesis ,occlusal evaluation,change in
prosthesis design.
-Anti-infective therapy- removal of plaque ,polishing of all accessible surface with
pumice, subgingival irrigation of peri-implant pockets with 0.12% chlorhexidine,systemic
anti microbial therapy for 10 consecutive days.
Surgical techniques for treatment of peri-implantitis.
Indications for resective therapy are
-moderate to advanced bone loss
-one and two wall bone defect
-implant position in nonaesthetic area
Apically displaced flap techinique and osseous resective therapy are used to correct
horizontal bone loss and moderate vertical bone defects and to reduce overall pocket depth.
69. Surface polishing :Implantoplasty- surfaces with threads or roughened topography (eg
hydroxyapatite)should be altered with high speed diamond burs and polishers to produce
a smooth continous surface. It is performed before osseous resective therapy.
Peri-implant regenerative therapy
-Guided tissue regeneration and bone graft technique have been suggested.
Maintenance
every three months
70. Moderate to severe peri-implantitis with soft tissue
Removal of implants 6 months before surgery
And one week of antibiotic therapy
Hyperplasia and deep pockets
71. Elevated flap showing bone loss around implants
Membranes placed over the peri-implant bone defect
73. NON STEROIDAL ANTI-INFLAMMATORY
ANALGESICS
Classification:
1. Analgesic and anti-inflammatory.
2. Analgesic but poor antiinflammatory.
1. Analgesic and antiinflammatory:
a. Salicylates- e.g. Aspirin, salicylamide.
b. Pyrazolone derivatives – e.g. Phenylbutazone,
oxyphenbutazone.
c. Indole derivatives – e.g. Etodolac, indomethacin.
d. Propionic acid derivatives – e.g. Ibuprofen, naproxen,
ketoprofen, fenoprofen.
e. Anthranitic acid derivatives – e.g. Mephenamic acid,
enfenamic acid.
f. Aryl-acetic acid derivatives – e.g. diclofenac.
g. Oxicam derivatives – e.g. piroxicam.
h. Pyrrolo-pyrrole derivatives – e.g. ketorolac.
74. Analgesic but poor antiinflammatory:
a. Para aminophenol derivatives – e.g. Paracetamol
(Acetaminophen).
b. Pyrazolone derivatives – E.g. Metamizol, Propiphenazone.
c. Benzoxazocine derivatives – E.g. Nefopam.
Mechanism of Action:
NSAID’s are peripherally acting because their analgesic and anti
inflammatory effects are, to a large extent, produced through a peripheral
mechanism.
They block the cyclooxygenase pathway by inhibiting cycloxygenase, an
enzyme involved in the biosynthesis of arachidonic acid into prostaglandins,
which are involved in the pain mechanism.
There are 2 isoforms of cyclooxygenase COX-1 and COX-2 and although all
NSAID’s inhibit both forms, the two isoforms differ slightly in their
sensitivity to NSAID inhibition.
75. This difference becomes therapeutically important because COX-2
appears to be more involved with synthesis of prostaglandins at sites
of inflammation, whereas COX-1 is more involved at sites where
adverse effects of NSAID’s are expressed.
Aspirin is the classic and prototypical drug and along with NSAID’s is
more effective for the intermittent, sharp pain caused by inflammation
which is characteristic of dental pain.
76. • Glucocorticiods:
are powerful anti-inflammatory agents
• They may act by down regulating the expression
of specific target genes including COX-2 genes
encoding cytokines( IL-1 and TNF)
• They also upregulate genes that encode potent
anti-inflammatory proteins such as lipocortin
• Lipocortin 1 inhibits the release of AA from
membrane phospholipids
77. CONCLUSION
• WAR AND INFLAMMATION Both are more-or-less stereotyped
responses to outside threats. There are specialized troops (white cells),
including suicide-commandos (neutrophils), long-term siege armies
(granulomas), and many others. There are supply routes (vessels),
communications and intelligence (mediators), and a huge array of
lethal weapons (inflammatory enzymes). In war as in inflammation,
there will be damage to both the enemy and to friendly forces, and
there will very likely be severe damage to the battlefield itself. Despite
idealistic rhetoric about "the laws of war", when the fighting starts,
there is really only one law for the soldiers: "Kill your enemy." Like it
or not, if you want peace, you must be prepared to fight under certain
conditions. Like it or not, if you want to be healthy, your body must be
able to mount an inflammatory response. Force will always rule our
world. Our best hope is that this will be the force of good laws. And
the best for which we can hope from the inflammatory response is
that, for most of our lives, it will do us more good than harm.
• Probably your own death will be caused by your last
inflammatory response.
78. REFERENCES
• Kumar, Cotran, Robbins, Basic Pathology, sixth edition
• Trowbridge,Emling, Inflammation A Review of The Process
third edition
• Govan,McFarlane, Pathology Illustrated fourth edition
• Harsh Mohan, Textbook of Pathology, second edition
• Carranza,Newman, Clinical Periodontology , eighth edition
• Zarb,Bolender, Prosthodontic treatment for edentulous patients
twelfth edition
• William F.P.Malone, Tylman’s theory and practice of fixed
prosthodontics, eigth edition
• Carl E Mish, Implant Dentistry, second edition